The Anti-fibrotic Hormone Relaxin is not Reno-protective, Despite Being Active, in an Experimental Model of Type 1 Diabetes
Su Ee Wong, Chrishan S Samuel, Darren J Kelly, Yuan Zhang, Gavin J Becker, Tim D Hewitson
Protein and Peptide Letters | BENTHAM SCIENCE PUBL LTD | Published : 2013
We thank Ms Mariana Pacheco, Ms Belinda Wigg and Ms Chongxin Zhao for technical assistance; A/Prof Ross Bathgate for designing the RXFP1 (PCR) primers used; Prof. Richard Ivell for providing the RXFP1 (L7-2) antibody; and Corthera Inc (San Mateo, CA) for generously providing the rH2-RLX used in these studies. This study was supported by Project Grant funding from the Diabetes Australia Research Trust (DART), National Health & Medical Research Council of Australia (NHMRC), and a National Heart Foundation of Australia/NHMRC R. D. Wright Fellowship to Chrishan S. Samuel.